Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Paj 1 soti nan 19 rezilta yo
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
This invention relates to prevention and treatment of various infectious agents and in particular, relates to inhibitory activity of cellulose sulfate and other sulfated polysaccharides against various infectious agents, including papilloma virus and various vaginitis-causing
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
This invention relates to prevention and treatment of various infectious agents and in particular, relates to inhibitory activity of cellulose sulfate and other sulfated polysaccharides against various infectious agents, including papilloma virus and various vaginitis-causing
Nutritional composition
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present invention relates to a nutrient composition (nutritional composition) having lipid metabolism-improving action. The nutrient composition highly effectively contributes to decrease of neutral lipids (triglycerides). The nutrient composition is expected to offer
Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FEDERALLY SPONSORED RESEARCH STATEMENT
Not applicable.
FIELD OF THE INVENTION
The present invention relates to novel compositions for and methods of treating symptoms, syndromes, pathological conditions and disease-associated problems mediated by oxidative stress. These conditions include cancer,
Ondansetron orally disintegrating tablets
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to non-effervescent, solid dosage forms adapted for oral administration of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carb- azol-4-one (ondansetron) as an anti-emetic active
Recognins and their chemoreciprocals
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
THE INVENTION
This invention is directed to a novel group of compounds, herein termed Recognins. Recognins are made by treating normal or diseased cells or tissues, e.g. tumor cells or artificial cancer cells and separating the desired products. The Recognins may be used to prepare their
Compositions containing micronized tanaproget prepared by wet granulation
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Micronized tanaproget and compositions containing the same are provided.
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family,
Compositions containing micronized tanaproget prepared by wet granulation
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Micronized tanaproget and compositions containing the same are provided.
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family,
Micronized tanaproget, compositions, and methods of preparing the same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Micronized tanaproget, compositions, and methods of preparing the same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Micronized tanaproget, compositions, and methods of preparing the same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Micronized tanaproget and compositions containing same
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Solid dosage forms of oleyl phosphocholine
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention relates to solid dosage forms of oleyl phosphocholine (C18:1-PC), or OlPC, for oral administration. Further, the present invention relates to methods for the preparation of the present solid dosage forms and the use thereof as a medicament and especially a medicament for the
Dosage forms having prolonged active ingredient release
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
RELATED APPLICATIONS
This is a National Stage of International Application Number PCT/CH02/00486, filed Sep. 4, 2002, which claims priority of EP patent application 01810865.4 filed Sep. 10, 2001.
FIELD OF THE INVENTION
The invention relates to solid, orally administrable pharmaceutical dosage forms
Extract of Lepidium meyenii roots for pharmaceutical applications
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention relates to compositions containing particular components that can be obtained from a plant which can have pharmaceutical applications. More particularly, the plant genus is Lepidium.
Lepidium meyenii, commonly called maca or Peruvian ginseng, is a perennial plant having a
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
